Evidence map›Paper›PMID 40145295›Full record

ArticleHaematologica2025

Genetic and clinical characteristics of patients with Shwachman Diamond syndrome with special consideration of treatment with granulocyte-colony stimulating factor.

Sabine Mellor-Heineke, Julia Skokowa, Natali Gerschmann, Ekaterina Deordieva, Ivan Tesakov, Sally Kinsey, Maja Klaudel-Dreszler, Piero Farruggia, Martina Sukova, Mikael Sundin and 9 more

Abstract read
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sabine Mellor-HeinekeDepartment of Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany; Children's Hospital, University Hospital Mannheim, Mannheim. Sabine.Mellor-Heineke@med.uni-tuebingen.de.
Julia SkokowaDepartment of Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany; Gene and RNA Therapy Center (GRTC), University Hospital Tübingen, Tübingen.
Natali GerschmannClinic for Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover.
Ekaterina DeordievaD. Rogachev National Medical and Research Center for Pediatric Hematology, Oncology and Immunology, Moscow.
Ivan TesakovDepartment of Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen.
Sally KinseyLeeds Institute for Medical Research, University of Leeds, Leeds.
Maja Klaudel-DreszlerInstytut Pomnik "Centrum Zdrowia Dziecka", Klinika Gastroenterologii, Hepatologii, Zaburzeń Odżywiania i Pediatrii, Warsaw.
Piero FarruggiaPediatric Onco-Hematology, ARNAS Civico Di Cristina Benfratelli Hospital, Palermo.
Martina SukovaDept. Pediatric Hematology-Oncology, University Hospital Motol, Prague, Czech Republic.
Mikael SundinPediatric Hematology, Immunology and HCT, Astrid Lindgren Children's Hospital, Stockholm.
Yasmine El ChazliDepartment of Pediatric Hematology and Oncology, Alexandria University Children's Hospital, Alexandria.
Tania N MasmasPediatric Hematopoietic Stem Cell Transplantation and Immunodeficiency, The Child and Adolescent Clinic, Copenhagen University Hospital, Copenhagen.
Leen WillemsAfdeling Hemato-oncologie en stamceltransplantatie kinderen, Kinderziekenhuis Prinses Elisabeth, University of Gent, Gent.
Georg Ebetsberger-DachsDepartment of Paediatrics and Adolescent Medicine, Kepler University Hospital, Linz.
Hans C ErichsenDept. Pediatric Hematology-Oncology, Immunology, Rikshospitalet, Oslo University Hospital, Oslo.
Orna Steinberg-ShemerThe Rina Zaizov Hematology-Oncology Division, Schneider Children's Medical Center of Israel. Petah Tikva.
Anna ShcherbinaD. Rogachev National Medical and Research Center for Pediatric Hematology, Oncology and Immunology, Moscow.
Karl WelteUniversity Children's Hospital Tübingen, Tübingen.
Cornelia ZeidlerDepartment of Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen.

Funding

Systems Biology of Bone Marrow Failure and MDS for Precision MedicineRC2DK122533 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FIGUEROA, MARIA EUGENIA, FLEMING, MARK D · 2019 to 2023
$6.4M
Severe Chronic Neutropenia International RegistryR24AI162637 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI PETER E NEWBURGER, Akiko Shimamura · 2022 to 2026
$5.8M
NIAID NIH HHS R24 AI162637NIDDK NIH HHS RC2 DK122533
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40145295
PMCPMC12399964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.